AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
| Website: | www.aikidopharma.com |
| Email: | info@spherix.com |
| Main Phone: | +1 703 992-9325 |
| Address: | One Rockefeller Plaza |
| Address 2: | 11th Floor |
| State: | NY |
| City / Town: | New York |
| Country: | US |
| Postal Code: | 10020 |
| Exchange: | NSC |
| CEO: | Anthony Hayes |
| Employees: | 3 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
| Website: | www.aikidopharma.com |
| Email: | info@spherix.com |
| Main Phone: | +1 703 992-9325 |
| Address: | One Rockefeller Plaza |
| Address 2: | 11th Floor |
| State: | NY |
| City / Town: | New York |
| Country: | US |
| Postal Code: | 10020 |
| Exchange: | NSC |
| CEO: | Anthony Hayes |
| Employees: | 3 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume 0 | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 13,773,602.00 | EPS (TTM) -1.57 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 3 |
| Number of Buys | 0 | 3 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 60000 |
| Last 10 Buys | Shares |
|---|---|
| Anthony Hayes | 1,000 |
| Robert J. Vander Zanden | 1,000 |
| Anthony Hayes | 1,000 |
| Anthony Hayes | 1,000 |
| Anthony Hayes | 1,000 |
| Anthony Hayes | 1,000 |
| Harvey J. Kesner | 1,000 |
| Harvey J. Kesner | 1,000 |
| Harvey J. Kesner | 1,000 |
| Harvey J. Kesner | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Harvey J. Kesner | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 20 | 20 | 20 | 20 |
| Low Target Price Estimate | 20 | 20 | 20 | 20 |
| Mean Target Price Estimate | 20 | 20 | 20 | 20 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 08/16/12 | 08/16/12 | 08/16/12 | 08/16/12 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 25 | 2018-05-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-07 |
| DEFA14A | Additional proxy soliciting materials - definitive | 10 | 2018-05-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 10 | 2018-05-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-04-09 |
| 425 | Filing of certain prospectuses and communications in connection with business combination transactions | 5 | 2018-04-09 |
| 10-K | Annual report with a comprehensive overview of the company | 80 | 2018-03-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-03-28 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 3 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait 